Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Shattuck Labs Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
STTK
Nasdaq
8731
https://www.shattucklabs.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Shattuck Labs Inc
Shattuck Labs to Present Complete Dose-Escalation Data from Phase 1A Monotherapy Clinical Trial of SL-172154 in Platinum-Resistant Ovarian Cancer (PROC) at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
- May 25th, 2023 9:15 pm
Shattuck Labs, Inc. (STTK) Reports Q1 Loss, Misses Revenue Estimates
- May 9th, 2023 9:15 pm
Shattuck Labs Reports First Quarter 2023 Financial Results and Recent Business Highlights
- May 9th, 2023 8:00 pm
Shattuck Labs Announces Participation in Upcoming 22nd Annual Needham Virtual Healthcare Conference
- Apr 3rd, 2023 11:00 am
Great week for Shattuck Labs, Inc. (NASDAQ:STTK) institutional investors after losing 37% over the previous year
- Mar 21st, 2023 3:50 pm
Shattuck Labs Presents Preclinical Data at the 2023 American Association for Cancer Research (AACR) Annual Meeting
- Mar 16th, 2023 12:31 pm
Shattuck Labs Announces Participation in Upcoming March Conferences
- Mar 1st, 2023 12:00 pm
Shattuck Labs, Inc. (NASDAQ:STTK) Q4 2022 Earnings Call Transcript
- Feb 28th, 2023 3:46 am
Shattuck Labs Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides Business Updates
- Feb 23rd, 2023 9:30 pm
Shattuck Labs to Report Fourth-Quarter and Full-Year 2022 Financial Results on February 23, 2023
- Feb 16th, 2023 12:00 pm
Shattuck Labs Announces Participation in Upcoming SVB Securities Global Biopharma Conference
- Feb 9th, 2023 11:01 am
We Think Shattuck Labs (NASDAQ:STTK) Needs To Drive Business Growth Carefully
- Jan 27th, 2023 1:34 pm
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2023
- Jan 9th, 2023 12:00 pm
Multiple insiders bought Shattuck Labs, Inc. (NASDAQ:STTK) stock earlier this year, a positive sign for shareholders
- Dec 13th, 2022 11:51 am
Shattuck Labs, Inc. (STTK) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
- Dec 1st, 2022 2:55 pm
Shattuck Labs Third Quarter 2022 Earnings: US$0.58 loss per share (vs US$0.41 loss in 3Q 2021)
- Nov 11th, 2022 10:51 am
Shattuck Labs Reports Third Quarter 2022 Financial Results and Recent Business Highlights
- Nov 8th, 2022 9:30 pm
Shattuck Labs Presents Updated Preclinical Data on Gamma Delta T Cell Engager (GADLEN) Platform Candidates at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
- Nov 7th, 2022 1:00 pm
Investors in Shattuck Labs (NASDAQ:STTK) have unfortunately lost 86% over the last year
- Nov 4th, 2022 3:55 pm
Shattuck Labs Announces Participation in Upcoming November Conferences
- Nov 3rd, 2022 12:30 pm
Scroll